Volume 53, Issue 3 pp. 1070-1071
Correspondence
Free Access

Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices?

Li-Ping Ye M.D.

Li-Ping Ye M.D.

Department of Gastroenterology Taizhou Hospital of Zhejiang Province Linhai, China

Search for more papers by this author
Xin-Li Mao M.D.

Xin-Li Mao M.D.

Department of Gastroenterology Taizhou Hospital of Zhejiang Province Linhai, China

Search for more papers by this author
First published: 06 October 2010

Potential conflict of interest: Nothing to report.

To the Editor:

We read with great interest the study by Bruno et al., which concluded that achievement of sustained virologic response prevents the development of esophageal varices in patients with compensated hepatitis C virus (HCV)-induced cirrhosis. Their multivariable analysis also showed that HCV genotype 1b is an independent predictor for the development of esophageal varices.1 The interpretation of the results, however, raises a concern.

It is well known that the clinical outcome of antiviral therapy is significantly influenced by viral genotype.2, 3 That is to say, patients with different HCV genotypes may have different responses to the antiviral therapy. This is confirmed by the observation that patients infected with genotype 1b have lower rate of sustained virologic response.1 Therefore, HCV genotype 1b may be more likely to be an independent predictor for the development of esophageal varices, and achievement of sustained virologic response may be merely a cofactor associated with the host response to antiviral therapy. Further study is needed to clarify this concern.

Li-ping Ye M.D.*, Xin-li Mao M.D.*, * Department of Gastroenterology Taizhou Hospital of Zhejiang Province Linhai, China.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.